[go: up one dir, main page]

WO2011061609A3 - Processes for the preparation of cilastatin - Google Patents

Processes for the preparation of cilastatin Download PDF

Info

Publication number
WO2011061609A3
WO2011061609A3 PCT/IB2010/002962 IB2010002962W WO2011061609A3 WO 2011061609 A3 WO2011061609 A3 WO 2011061609A3 IB 2010002962 W IB2010002962 W IB 2010002962W WO 2011061609 A3 WO2011061609 A3 WO 2011061609A3
Authority
WO
WIPO (PCT)
Prior art keywords
cilastatin
processes
preparation
pharmaceutically acceptable
acceptable salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2010/002962
Other languages
French (fr)
Other versions
WO2011061609A2 (en
Inventor
Suresh Babu Jayachandra
Ruchika Yogesh
Raghuram Morampudi
Chandra Has Khanduri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2011061609A2 publication Critical patent/WO2011061609A2/en
Anticipated expiration legal-status Critical
Publication of WO2011061609A3 publication Critical patent/WO2011061609A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C07C323/59—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton with acylated amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides improved process for preparing substantially pure cilastatin and pharmaceutically acceptable salts thereof.
PCT/IB2010/002962 2009-11-19 2010-11-19 Processes for the preparation of cilastatin Ceased WO2011061609A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2387/DEL/2009 2009-11-19
IN2387DE2009 2009-11-19

Publications (2)

Publication Number Publication Date
WO2011061609A2 WO2011061609A2 (en) 2011-05-26
WO2011061609A3 true WO2011061609A3 (en) 2012-07-26

Family

ID=43928116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2010/002962 Ceased WO2011061609A2 (en) 2009-11-19 2010-11-19 Processes for the preparation of cilastatin

Country Status (1)

Country Link
WO (1) WO2011061609A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102875433A (en) * 2012-10-29 2013-01-16 江西金顿香料有限公司 Preparation method of cilastatin acid
CN103709035B (en) * 2013-03-15 2015-09-02 衡水衡林生物科技有限公司 A kind of preparation method of 7-chloro-2-oxoheptanoate
CN104649948B (en) * 2013-11-19 2017-05-24 江苏迪赛诺制药有限公司 Cilastatin calcium crystal, preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
WO2007054771A2 (en) * 2005-11-09 2007-05-18 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of cilastatin and sodium salt
US7371897B1 (en) * 2006-12-11 2008-05-13 Wischem Co., Ltd. Preparation method for (Z)-7-chloro-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147868A (en) * 1978-07-24 1992-09-15 Merck & Co., Inc. Thienamycin renal peptidase inhibitors
WO2007054771A2 (en) * 2005-11-09 2007-05-18 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of cilastatin and sodium salt
US7371897B1 (en) * 2006-12-11 2008-05-13 Wischem Co., Ltd. Preparation method for (Z)-7-chloro-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
GRAHAM D W ET AL: "INHIBITION OF THE MAMMALIAN BETA-LACTAMASE RENAL DIPEPTIDASE (DEHYDROPEPTIDASE-I) BY (Z)-2-(ACYLAMINO)-3-SUBSTITUTED-PROPENOIC ACIDS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 30, 1 January 1987 (1987-01-01), pages 1074 - 1090, XP001064529, ISSN: 0022-2623, DOI: 10.1021/JM00389A018 *
VINOGRADOV M G ET AL: "Chemistry of natural compounds and bioorganic chemistry, a new approach to the synthesis of cilastatin, and inhibitor of renal dipeptidase", RUSSIAN CHEMICAL BULLETIN, SPRINGER NEW YORK LLC, US; RU, vol. 44, no. 1, 1 January 1995 (1995-01-01), pages 167 - 171, XP002636765, ISSN: 1066-5285, DOI: 10.1007/BF00696982 *

Also Published As

Publication number Publication date
WO2011061609A2 (en) 2011-05-26

Similar Documents

Publication Publication Date Title
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
WO2009084024A3 (en) A process for the preparation of r-sit agliptin and its pharmaceutically acceptable salts thereof
WO2011022596A3 (en) Preparation of bazedoxifene and its salts
WO2011060213A3 (en) Preparation of sitagliptin and salts thereof
WO2013098833A3 (en) Processes and intermediates for preparing rivaroxaban
IL238337A (en) Process for the manufacture of pharmaceutically active compounds
WO2010092090A3 (en) Novel salts of sitagliptin
WO2011025932A3 (en) Preparation of sitagliptin and salts thereof
WO2014041565A3 (en) Improved process for preparation of vilanterol and intermediates thereof
EP3214066B8 (en) Process for the preparation of fluoroalkyl fluoroformates
IL231141A (en) Process for the preparation of 2-(6-fluoro-1h-indol-3-yl)-n,n-dimethylmethanamine
WO2012146980A3 (en) Preparation of fingolimod and its salts
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
AU2009254929A8 (en) An improved process for the preparation of amines
WO2010148314A3 (en) Preparation of esomeprazole and its pharmaceutically acceptable salts
WO2011018771A3 (en) Process for the preparation of valganciclovir hydrochloride
WO2011023954A3 (en) Polymorphic forms of manidipine
WO2012018791A3 (en) Preparation of prasugrel hydrochloride
PH12013500210A1 (en) Highly crystalline valsartan
WO2011061609A3 (en) Processes for the preparation of cilastatin
EP2364967A8 (en) Process for preparation of rasagiline and salts thereof
WO2011107921A3 (en) Modified release composition of milnacipran
IL218322A0 (en) Process for the preparation of (1s,4r)-2-oxa-3-azabicyclo[2,2,1]hept-5-enes
WO2010036904A3 (en) Preparation of valganciclovir and its salts
WO2013114397A3 (en) Pharmaceutically acceptable salt of brinzolamide and composition thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10801461

Country of ref document: EP

Kind code of ref document: A2